scholarly article | Q13442814 |
P2093 | author name string | Endoh M | |
Taira N | |||
Yanagisawa T | |||
Blinks JR | |||
P433 | issue | 3 Pt 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | III117-33 | |
P577 | publication date | 1986-03-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle | |
P478 | volume | 73 |
Q35007243 | A low-dose β1-blocker in combination with milrinone improves intracellular Ca2+ handling in failing cardiomyocytes by inhibition of milrinone-induced diastolic Ca2+ leakage from the sarcoplasmic reticulum |
Q43600533 | A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment |
Q68073754 | A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts |
Q44078545 | Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure |
Q42011402 | An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria |
Q36932457 | Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. |
Q37302824 | Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome |
Q68424322 | Comparative effects of enoximone and theophylline on plasma catecholamines and haemodynamics in cardiosurgical patients |
Q67685677 | Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria |
Q67691488 | Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram |
Q41584608 | Could Ca2+ sensitizers rescue patients from chronic congestive heart failure? |
Q69242850 | Differential effects of reoxygenation on intracellular calcium and isometric tension |
Q42607945 | Does levosimendan act as Ca(2+) sensitizer or PDE3 inhibitor? |
Q68077867 | Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle |
Q41875562 | Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes |
Q46154248 | Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease |
Q46761465 | Involvement of purine compounds in the inotropic action of milrinone |
Q34534329 | J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge |
Q87886309 | J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge |
Q55059903 | J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. |
Q26859366 | J-wave syndromes: Brugada and early repolarization syndromes |
Q39534050 | Milrinone. A preliminary review of its pharmacological properties and therapeutic use. |
Q44321768 | New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase |
Q67270678 | OPC-8212 in the treatment of congestive heart failure: results of a pilot study |
Q46577023 | Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium |
Q42493953 | Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism |
Q39148010 | Selective updates on mechanisms of action of positive inotropic agents |
Q38303668 | Studies on the mechanism of action of the bipyridine milrinone on the heart |
Q68257142 | Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium |
Q67661700 | Sulmazole (AR-L 115BS) activates the sheep cardiac muscle sarcoplasmic reticulum calcium-release channel in the presence and absence of calcium |
Q97526210 | The effect of milrinone on mortality in adult patients who underwent CABG surgery: a systematic review of randomized clinical trials with a meta-analysis and trial sequential analysis |
Q67711480 | The effects of milrinone in the neonatal pig heart |
Q68194402 | The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes |
Q38215901 | The rationale for combined use of diuretics, digitalis, and vasodilators in congestive heart failure |
Search more.